Nathan Kilah does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Under the proposed settlement, the biotechnology company will pay $31.25 million to fully resolve all claims related to the litigation, which covers investors who bought Cassava common stock or call ...

In other recent news, Cassava Sciences, Inc. has reached a settlement in a securities class action lawsuit for $31.25 million. This agreement resolves litigation that was initially filed in 2021, ...

AUSTIN, Texas, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for ...

Cassava Sciences Inc. (NASDAQ: SAVA) received a formal letter from the U.S. Food and Drug Administration (FDA) related to the company’s trial for simufilam Following previously reported communications ...

Cassava Sciences, Inc. (NASDAQ:SAVA) announced that the U.S. Food and Drug Administration has placed a full clinical hold on the company’s proposed proof-of-concept clinical trial of simufilam for ...

Former President of Botswana, Mokgweetsi Masisi, has said Africa possesses the capacity to meet global cassava demand if the right policies, investments and technological innovations are deployed ...

Christmas pudding is a traditional Christmas dessert made with a combination of dried fruits, nuts, eggs or molasses, spices, flour and butter. Steaming is generally the cooking method used to prepare ...

Pan-African technology group Cassava Technologies has partnered with AI-powered tools provider Gebeya to launch Gebeya Dala, a suite of artificial intelligence tools designed to help Africans create ...

Nvidia Corp.-backed Cassava Technologies plans to raise as much as $700 million to build and upgrade a network of data centers across Africa with artificial intelligence chips, with the goal of making ...